Stockreport

Will 2026 FDA Decisions on Afrezza and FUROSCIX Redefine MannKind's (MNKD) Narrative [Yahoo! Finance]

MannKind Corporation  (MNKD) 
Last mannkind corporation earnings: 2/25 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.mannkindcorp.com/press-releases
PDF These potential approvals could broaden Afrezza's use into pediatrics while adding a new needle-free diuretic delivery option, sharpening MannKind's focus on inhaled an [Read more]